Published in the Journal of Clinical Oncology, a review paper authored by a multidisciplinary group of international experts in DNA Damage Response (DDR) and PARP inhibition
Oncology
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Dr Judith Balmaña
Dr Rebecca Dent
Prof. Simon Boulton
Prof. Sibylle Loibl
Prof. Eric Pujade-Lauraine
Prof. Charlie Gourley
Dr Violeta Serra
Prof. Jonathan A. Ledermann
Publication Date
Sep 2021
Dr Judith Balmaña has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca.
Dr Rebecca Dent has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Eisai, Genentech, Lilly, Merck, Novartis, Pfizer and Roche.
Prof. Simon Boulton has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Artios Pharma Ltd.
Prof. Sibylle Loibl has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Amgen, Novartis, Pfizer and Roche.
Prof. Eric Pujade-Lauraine has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Clovis, Pfizer, Roche and Tesaro.
Prof. Charlie Gourley has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Apera, Clovis, MSD, Nucana, Novartis, Roche, Sierra Oncology and Tesaro.
Dr Violeta Serra has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca and Tesaro.
Prof. Jonathan A. Ledermann has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Clovis, Cristal Therapeutics, Pfizer, Roche and Seattle Genetics.
Programme summary
Duration 10 MIN
Downloadable resources Yes-
DOWNLOAD THE SLIDES
-
Language(s)
Share this programme
Other programmes of interest
Video
Oncology
The emerging role of artificial intelligence in precision oncology
Expert opinion on the clinical application of artificial intelligence (AI)
Experts
Prof. Albrecht Stenzinger-
Downloadable
Resources -
6 MIN
-
Nov 2024
Podcast
Oncology
BRAF-mutated CRC: from testing to treatment
Medical experts share insights and review key clinical trials
Experts
Prof. Sebastian Stintzing, Dr Thomas WinderEndorsed by
-
Downloadable
Resources -
25 MIN
-
Nov 2024
Other
Oncology
Biomarker testing in NSCLC: patient and caregiver awareness and understanding
Findings from a global survey presented in a poster at ESMO 2024
Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos, Dr. Rodrigo Paredes, Amy Moore, Anne-Marie Baird, Shani ShiloEndorsed by
-
Downloadable
Resources -
5 MIN
-
Sep 2024
Podcast
Oncology Rare diseases
Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments
Experts
Dr Mohid S Khan, Sally JenkinsEndorsed by
-
Downloadable
Resources -
23 MIN
-
Sep 2024
Conference update
Oncology
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers
Renowned medical experts share their insights into new data presented at ESMO 2024
-
Downloadable
Resources -
5 MIN
-
Sep 2024
Animated Video
Episode
1
of 1
Oncology
Precision oncology in prostate cancer: tips for optimal genomic testing
From sample collection through to diagnostic modalities
Experts
Dr Alexander WyattEndorsed by
-
Downloadable
Resources -
5 MIN
-
Sep 2024